The price of Cronos Group Inc (NASDAQ: CRON) closed at $2.67 in the last session, down -1.11% from day before closing price of $2.70. In other words, the price has decreased by -$0.0300 from its previous closing price. On the day, 4928758 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
We take a closer look at CRON’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 21.81 and its Current Ratio is at 22.54. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Bernstein on November 02, 2022, initiated with a Mkt Perform rating and assigned the stock a target price of $3.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 30 ’23 when ADLER JASON MARC bought 37,500 shares for $1.74 per share. The transaction valued at 65,074 led to the insider holds 1,402,304 shares of the business.
ADLER JASON MARC bought 100,000 shares of CRON for $179,650 on May 25 ’23. The Director now owns 1,376,054 shares after completing the transaction at $1.80 per share. On May 23 ’23, another insider, ADLER JASON MARC, who serves as the Director of the company, bought 100,000 shares for $1.90 each. As a result, the insider paid 190,220 and bolstered with 1,306,055 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRON now has a Market Capitalization of 1.01B and an Enterprise Value of 155.55M. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.58 while its Price-to-Book (P/B) ratio in mrq is 0.93. Its current Enterprise Value per Revenue stands at 1.78 whereas that against EBITDA is -2.17.
Stock Price History:
Over the past 52 weeks, CRON has reached a high of $2.99, while it has fallen to a 52-week low of $1.64. The 50-Day Moving Average of the stock is 2.2560, while the 200-Day Moving Average is calculated to be 2.0331.
Shares Statistics:
According to the various share statistics, CRON traded on average about 2.84M shares per day over the past 3-months and 5.34M shares per day over the past 10 days. A total of 381.30M shares are outstanding, with a floating share count of 198.81M. Insiders hold about 47.86% of the company’s shares, while institutions hold 12.37% stake in the company. Shares short for CRON as of Mar 15, 2024 were 6.44M with a Short Ratio of 2.27, compared to 6.67M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.69% and a Short% of Float of 3.21%.
Earnings Estimates
The company has 2 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.01 for the current quarter, with a high estimate of -$0.01 and a low estimate of -$0.01, while EPS last year was -$0.05. The consensus estimate for the next quarter is -$0.01, with high estimates of -$0.01 and low estimates of -$0.01.
Analysts are recommending an EPS of between -$0.02 and -$0.21 for the fiscal current year, implying an average EPS of -$0.08. EPS for the following year is -$0.06, with 2 analysts recommending between $0.01 and -$0.13.
Revenue Estimates
According to 3 analysts, the current quarter’s revenue is expected to be $23.78M. It ranges from a high estimate of $25.1M to a low estimate of $22.7M. As of the current estimate, Cronos Group Inc’s year-ago sales were $20.14M, an estimated increase of 18.10% from the year-ago figure. For the next quarter, 3 analysts are estimating revenue of $24.5M, an increase of 28.80% over than the figure of $18.10% in the same quarter last year. There is a high estimate of $25.9M for the next quarter, whereas the lowest estimate is $23.3M.
A total of 7 analysts have provided revenue estimates for CRON’s current fiscal year. The highest revenue estimate was $105.07M, while the lowest revenue estimate was $98M, resulting in an average revenue estimate of $100.98M. In the same quarter a year ago, actual revenue was $87.24M, up 15.70% from the average estimate. Based on 4 analysts’ estimates, the company’s revenue will be $120.24M in the next fiscal year. The high estimate is $141.7M and the low estimate is $107.5M. The average revenue growth estimate for next year is up 19.10% from the average revenue estimate for this year.
